GlassScriptPhysician profile
Angela R Mccool-Pearson
NPI 1154445724
$57,136.48
in general payments reported to CMS, 2019-2025
26 companies · $38.24 in 2025
The $38.24 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $17K · 2021: $11K · 2022: $223 · 2023: $247 · 2024: $39.79 · 2025: $38.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319 · Education: $5.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.22 |
| Education | $5.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $52,716.68 | 2019-2021 | |
| Therapeuticsmd, INC. | $1,447.99 | 2019-2022 | |
| Applied Medical Resources Corporation | $1,177.41 | 2021 | |
| Coloplast Corp | $436.40 | 2021 | |
| Allergan, INC. | $348.01 | 2020-2021 | |
| Intuitive Surgical, INC. | $276.74 | 2019-2023 | Da Vinci Surgical System |
| Galderma Laboratories, L.P. | $201.20 | 2021-2024 | |
| Pfizer INC. | $97.65 | 2019-2022 | |
| Astellas Pharma US INC | $58.73 | 2019-2021 | |
| Bausch Health US, LLC | $58.55 | 2021-2022 | |
| Merz North America, INC. | $39.99 | 2024-2025 | |
| Mylan Pharmaceuticals INC. | $34.54 | 2021-2022 | |
| Agile Therapeutics, INC. | $28.50 | 2021-2022 | |
| Millicent US INC | $21.51 | 2020 | |
| Organon LLC | $21.46 | 2023 | Nexplanon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $21.32 | 2023 | Gemtesa |
| Mayne Pharma Commercial LLC | $20.46 | 2022 | |
| Hologic Sales and Service, LLC | $19.01 | 2025 | Aptima |
| Vertical Pharmaceuticals, LLC | $15.63 | 2020 | |
| Evofem Biosciences, INC. | $14.88 | 2022 | |
| Avion Pharmaceuticals | $14.18 | 2021 | |
| Duchesnay USA Incorporated | $14.17 | 2019 | |
| Myovant Sciences INC. | $13.67 | 2022 | |
| Meditrina | $13.53 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.47 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mccool-Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.